Literature DB >> 23681678

Rasagiline prevents apoptosis induced by PK11195, a ligand of the outer membrane translocator protein (18 kDa), in SH-SY5Y cells through suppression of cytochrome c release from mitochondria.

Makoto Naoi1, Wakako Maruyama, Hong Yi.   

Abstract

Rasagiline protects neuronal cells from cell death caused by various lines of insults. Its neuroprotective function is due to suppression of mitochondrial apoptosis signaling and induction of neuroprotective genes, including Bcl-2 and neurotrophic factors. Rasagiline inhibits the mitochondrial membrane permeabilization, an initial stage in apoptosis, but the mechanism has been elusive. In this paper, it was investigated how rasagiline regulates mitochondrial death cascade in apoptosis induced in SH-SY5Y cells by PK11195, a ligand of the outer membrane translocator protein of 18 kDa. Rasagiline prevented release of cytochrome c (Cyt-c), and the following caspase 3 activation, ATP depletion and apoptosis, but did not inhibit the mitochondrial membrane potential collapse, in contrast to Bcl-2 overexpression. Rasagiline stabilized the mitochondrial contact site and suppressed Cyt-c release into cytoplasm, which should be the critical point for the regulation of apoptosis. Monoamine oxidase was not associated with anti-apoptotic activity of rasagiline in PK11195-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23681678     DOI: 10.1007/s00702-013-1033-x

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  55 in total

1.  Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC.

Authors:  S Shimizu; M Narita; Y Tsujimoto
Journal:  Nature       Date:  1999-06-03       Impact factor: 49.962

Review 2.  Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopamine neurons.

Authors:  M Naoi; W Maruyama; Y Akao; J Zhang; H Parvez
Journal:  Toxicology       Date:  2000-11-16       Impact factor: 4.221

Review 3.  The therapeutic potential of monoamine oxidase inhibitors.

Authors:  Moussa B H Youdim; Dale Edmondson; Keith F Tipton
Journal:  Nat Rev Neurosci       Date:  2006-04       Impact factor: 34.870

Review 4.  Type A monoamine oxidase regulates life and death of neurons in neurodegeneration and neuroprotection.

Authors:  Makoto Naoi; Wakako Maruyama; Keiko Inaba-Hasegawa; Yukihiro Akao
Journal:  Int Rev Neurobiol       Date:  2011       Impact factor: 3.230

Review 5.  Mechanisms of cytochrome c release from mitochondria.

Authors:  C Garrido; L Galluzzi; M Brunet; P E Puig; C Didelot; G Kroemer
Journal:  Cell Death Differ       Date:  2006-05-05       Impact factor: 15.828

Review 6.  Monoamine oxidase inhibitors as neuroprotective agents in age-dependent neurodegenerative disorders.

Authors:  Makoto Naoi; Wakako Maruyama
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

7.  N-Propargyl-1 (R)-aminoindan, rasagiline, increases glial cell line-derived neurotrophic factor (GDNF) in neuroblastoma SH-SY5Y cells through activation of NF-kappaB transcription factor.

Authors:  Wakako Maruyama; Atusmi Nitta; Masayo Shamoto-Nagai; Yoko Hirata; Yukihiro Akao; Moussa Yodim; Shoei Furukawa; Toshitaka Nabeshima; Makoto Naoi
Journal:  Neurochem Int       Date:  2004-05       Impact factor: 3.921

8.  L-Deprenyl as an inhibitor of menadione-induced permeability transition in liver mitochondria.

Authors:  Umberto De Marchi; Paola Pietrangeli; Lucia Marcocci; Bruno Mondovì; Antonio Toninello
Journal:  Biochem Pharmacol       Date:  2003-11-01       Impact factor: 5.858

9.  Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease.

Authors:  F Blandini; M T Armentero; R Fancellu; E Blaugrund; G Nappi
Journal:  Exp Neurol       Date:  2004-06       Impact factor: 5.330

10.  Inactivation of purified human recombinant monoamine oxidases A and B by rasagiline and its analogues.

Authors:  Frantisek Hubálek; Claudia Binda; Min Li; Yaacov Herzig; Jeffrey Sterling; Moussa B H Youdim; Andrea Mattevi; Dale E Edmondson
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

View more
  12 in total

Review 1.  Neuroprotective and neurorestorative potential of propargylamine derivatives in ageing: focus on mitochondrial targets.

Authors:  Orit Bar-Am; Tamar Amit; Moussa B Youdim; Orly Weinreb
Journal:  J Neural Transm (Vienna)       Date:  2015-04-10       Impact factor: 3.575

2.  Phytochemicals prevent mitochondrial membrane permeabilization and protect SH-SY5Y cells against apoptosis induced by PK11195, a ligand for outer membrane translocator protein.

Authors:  Yuqiu Wu; Masayo Shamoto-Nagai; Wakako Maruyama; Toshihiko Osawa; Makoto Naoi
Journal:  J Neural Transm (Vienna)       Date:  2016-09-17       Impact factor: 3.575

3.  PROSPERA: a randomized, controlled trial evaluating rasagiline in progressive supranuclear palsy.

Authors:  Georg Nuebling; Mira Hensler; Sabine Paul; Andreas Zwergal; Alexander Crispin; Stefan Lorenzl
Journal:  J Neurol       Date:  2016-05-26       Impact factor: 4.849

4.  Rasagiline and selegiline suppress calcium efflux from mitochondria by PK11195-induced opening of mitochondrial permeability transition pore: a novel anti-apoptotic function for neuroprotection.

Authors:  Yuqiu Wu; Kimiko Kazumura; Wakako Maruyama; Toshihiko Osawa; Makoto Naoi
Journal:  J Neural Transm (Vienna)       Date:  2015-04-12       Impact factor: 3.575

Review 5.  Rasagiline and selegiline modulate mitochondrial homeostasis, intervene apoptosis system and mitigate α-synuclein cytotoxicity in disease-modifying therapy for Parkinson's disease.

Authors:  Makoto Naoi; Wakako Maruyama; Masayo Shamoto-Nagai
Journal:  J Neural Transm (Vienna)       Date:  2020-01-28       Impact factor: 3.575

6.  Type B and A monoamine oxidase and their inhibitors regulate the gene expression of Bcl-2 and neurotrophic factors in human glioblastoma U118MG cells: different signal pathways for neuroprotection by selegiline and rasagiline.

Authors:  Keiko Inaba-Hasegawa; Masayo Shamoto-Nagai; Wakako Maruyama; Makoto Naoi
Journal:  J Neural Transm (Vienna)       Date:  2017-06-02       Impact factor: 3.575

Review 7.  Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression.

Authors:  Makoto Naoi; Peter Riederer; Wakako Maruyama
Journal:  J Neural Transm (Vienna)       Date:  2015-01-22       Impact factor: 3.575

Review 8.  Programmed cell death in aortic aneurysm and dissection: A potential therapeutic target.

Authors:  Abhijit Chakraborty; Yang Li; Chen Zhang; Yanming Li; Scott A LeMaire; Ying H Shen
Journal:  J Mol Cell Cardiol       Date:  2021-09-28       Impact factor: 5.000

9.  Rasagiline prevents cyclosporine A-sensitive superoxide flashes induced by PK11195, the initial signal of mitochondrial membrane permeabilization and apoptosis.

Authors:  Yuqiu Wu; Masayo Shamoto-Nagai; Wakako Maruyama; Toshihiko Osawa; Makoto Naoi
Journal:  J Neural Transm (Vienna)       Date:  2016-03-02       Impact factor: 3.575

10.  Energy metabolism regulated by HDAC inhibitor attenuates cardiac injury in hemorrhagic rat model.

Authors:  Qiyuan Kuai; Chunyan Wang; Yanbing Wang; Weijing Li; Gongqing Zhang; Zhixin Qiao; Min He; Xuanlin Wang; Yu Wang; Xingwei Jiang; Lihua Su; Yuezhong He; Suping Ren; Qun Yu
Journal:  Sci Rep       Date:  2016-12-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.